Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008
Published online before print April 3, 2008, doi: 10.1161/CIRCRESAHA.108.174722
A more recent version of this article appeared on April 25, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/8/e65    most recent
CIRCRESAHA.108.174722v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by MacDonnell, S.
Right arrow Articles by Houser, S. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonnell, S.
Right arrow Articles by Houser, S. R.
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies
Right arrow Ion channels/membrane transport
Right arrowRelated Article

Submitted on February 26, 2008
Revised on March 17, 2008
Accepted on March 21, 2008

Adrenergic Regulation of Cardiac Contractility Does Not Involve Phosphorylation of the Cardiac Ryanodine Receptor at Serine 2808

Scott MacDonnell ; Gerardo García-Rivas ; Hajime Kubo ; Xiongwen Chen ; Joseph A. Scherman ; Héctor Valdivia ; and Steven R. Houser *

From the Department of Physiology (S.M., H.K., X.C., S.R.H.), Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pa; and Department of Physiology (G.G.-R., J.A.S., H.V.), University of Wisconsin Medical School, Madison.

* To whom correspondence should be addressed. E-mail: srhouser{at}temple.edu.

The sympathetic nervous system is a critical regulator of cardiac function (heart rate and contractility) in health and disease. Sympathetic nervous system agonists bind to adrenergic receptors that are known to activate protein kinase A, which phosphorylates target proteins and enhances cardiac performance. Recently, it has been proposed that protein kinase A–mediated phosphorylation of the cardiac ryanodine receptor (the Ca2+ release channel of the sarcoplasmic reticulum at a single residue, Ser2808) is a critical component of sympathetic nervous system regulation of cardiac function. This is a highly controversial hypothesis that has not been confirmed by several independent laboratories. The present study used a genetically modified mouse in which Ser2808 was replaced by alanine (S2808A) to prevent phosphorylation at this site. The effects of isoproterenol (a sympathetic agonist) on ventricular performance were compared in wild-type and S2808A hearts, both in vivo and in isolated hearts. Isoproterenol effects on L-type Ca2+ current (ICaL), sarcoplasmic reticulum Ca2+ release, and excitation–contraction coupling gain were also measured. Our results showed that isoproterenol caused significant increases in cardiac function, both in vivo and in isolated hearts, and there were no differences in these contractile effects in wild-type and S2808A hearts. Isoproterenol increased ICaL, the amplitude of the Ca2+ transient and excitation–contraction coupling gain, but, again, there were no significant differences between wild-type and S2808A myocytes. These results show that protein kinase A phosphorylation of ryanodine receptor Ser2808 does not have a major role in sympathetic nervous system regulation of normal cardiac function.


Key words: ryanodine receptor • PKA phosphorylation • excitation–contraction coupling • {beta}-adrenergic regulation


Related Article:

What Are the Consequences of Phosphorylation and Hyperphosphorylation of Ryanodine Receptors in Normal and Failing Heart?
John H.B. Bridge and Eleonora Savio-Galimberti
Circ. Res. 2008 102: 995-997. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Mattiazzi, L. Vittone, and C. Mundina-Weilenmann
Ca2+-Calmodulin-Dependent Protein Kinase Phosphorylation of Ryanodine Receptor May Contribute to the {beta}-Adrenergic Regulation of Myocardial Contractility Independently of Increases in Heart Rate
Circ. Res., July 3, 2008; 103(1): e10 - e11.
[Full Text] [PDF]


Home page
Circ. Res.Home page
H. H. Valdivia and S. R. Houser
Response to Mattiazzi et al:
Circ. Res., July 3, 2008; 103(1): e12 - e12.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. H.B. Bridge and E. Savio-Galimberti
What Are the Consequences of Phosphorylation and Hyperphosphorylation of Ryanodine Receptors in Normal and Failing Heart?
Circ. Res., May 9, 2008; 102(9): 995 - 997.
[Full Text] [PDF]